我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

胰岛素样生长因子I,脑钠尿肽与心功能分级关系(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2005年第6期
页码:
549-551
栏目:
基础研究
出版日期:
2005-12-05

文章信息/Info

Title:
Relationship between cardiac function and brain natriuretic peptide and Insulinlike growth factorI
作者:
孙卫红1戴向东1 陶金华1 刘玮1宋建平1 程绪杰2
1.昆山市第二人民医院心内科, 江苏 昆山 215300; 2.苏州大学附属第一人民医院心内科, 江苏 苏州 215000
Author(s):
SUN WeihongDAI XiangdongTAO JinhuaLIU WeiSONG JianpingCHENG Xujie
Department of Cardiology,Second Hospital of Kunshan,Kunshan,Jiangsu 215300,China
关键词:
脑钠尿肽胰岛素样生长因子I心力衰竭充血性超声心动描记术
Keywords:
Btype natriuretic peptide insulinlike growth factorIcongestive heart failure echocardiography
分类号:
R512.6
DOI:
-
文献标识码:
A
摘要:
目的 研究心力衰竭患者血浆胰岛素样生长因子I(IGFI)、脑钠尿肽(BNP)水平及其与心功能(NYHA)分级、心脏超声特征之间的关系。方法 心力衰竭患者78例,健康对照组18例。使用美国博适Triage干式快速定量心力衰竭/心肌梗死诊断仪定量快速(15 min)检测全血中BNP含量。用ELISA法检测血清中IGFI水平。并测量左心室收缩末期内径(LVESd)、左心室舒张末期内径(LVEDd)、左室后壁厚度(LVPWT)及左心室射血分数(LVEF)。结果 对照组、心功能Ⅰ,Ⅱ,Ⅲ,Ⅳ级组BNP值分别为41.3±11.4,156.3±15.1,338.4±23.4,596.4±33.2,972.4±25.4 ng/L,随着心功能分级加重,BNP呈上升趋势,呈正相关。LVEF分别为0.65±0.09,0.62±0.09,0.60±0.08,0.58±0.11,0.35±0.10,与BNP值呈负相关(r=-0.90,P<0.05)。IGFI值分别为166.7±62.5,158.2±55.3,203.5±63.7,240.7±67.3,107.8±66.4 μg/L。心功能Ⅱ级与Ⅰ级,Ⅲ级比较,差异有显著性(P<0.05);而心功能Ⅳ级患者的IGFⅠ水平降低,差异非常显著(P<0.01)。相关性分析显示IGFⅠ值与LVPWT呈正相关(r=0.75,P<0.05)。结论 左室功能不全的患者BNP值升高并与NYHA分级相关,可作为诊断心力衰竭的指标,心功能Ⅱ,Ⅲ级者IGFI水平明显上升,但Ⅳ级者明显降低,如结合BNP浓度可对心力衰竭的预后作出评价。IGFⅠ水平与左室后壁厚度呈正相关,在心功能Ⅳ级组IGFⅠ水平、室壁厚度及EF值均明显降低,提示IGFⅠ水平可能与心室重构有关。
Abstract:
AIM To investigate how brain natriuretic peptide and insulinlike growth factorI related with the class of cardiac function, feature of transthoracic echocardiography. METHODS Our study included 78 patients with heart failure and 18 healthy people as the control group. Patients were divided into different groups according to the classification of cardiac function. The level of brain natriuretic peptide was measured by fluorescence immunoassay (15 min) and the serum level of IGFI was measured by ELISA. All patients received routine transthoracic echocardiography. Left ventricular end systolic diameter, left ventricular end diastolic diameter, left ventricular posterior wall thickness and left ventricular ejection fraction were measured. RESULTS The levels of BNP in normal control group, grade I, grade II, grade Ⅲ and grade Ⅳ were 41.3±11.4,156.3±15.1,338.4±23.4,596.4±33.2 and 972.4±25.4 ng/L,respectively (P<0.01). BNP level was positively correlated with the grade of cardiac function,while it was negatively correlated with LVEF (r=-0.90,P<0.05). But IGFI levels in normal control group and grade Ⅰ-Ⅳ were 166.7±62.5,158.2±55.3,203.5±63.7,240.7±67.3,107.8±66.4 μg/L,respectively. There was significant difference between grade Ⅱ and gradeⅠ, grade Ⅲ and grade Ⅱ(P<0.05). IGFI decreased significantly in grade Ⅳ and showed statistical difference comparing with normal control group, gradeⅠ-Ⅲ and grade Ⅳ.The level of IGFI was positively correlated with the LVPWT(r=0.75,P<0.05). CONCLUSION BNP level is elevated in patients with left ventricular dysfunction and correlating with cardiac function and therefore it might be helpful in the diagnosis of heart failure. The level of IGFI is different in accordance with cardiac function. It increases significantly in grade Ⅱ,Ⅲ but decreases significantly in grade Ⅳ. IGFI combined with BNP level can be used to evaluate the prognosis of heart failure. The level of IGFI is positively correlated with the LVPWT and the levels of IGFI, LVPWT and LVEF decreases significantly in grade Ⅳ, indicating that IGFI level may be involved in left ventricular remodeling.

参考文献/References

[1] Krishnaswamy P,Lubien E,Clopton P,et al.Utility of Btype natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction[J]. Am J Med, 2001, 111:274-279.

[2] Cheng VL,Kazanegra R,Garcia A,et al.A rapid bedside test for Btype peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study[J]. J Am Coll Cardiol, 2001, 37:386-391.

[3] Maisel AS,Koon J,Krishnaswamy P,et al.Utility of B natriuretic peptide as a rapid, pointofcare test for screening patients undergoing echocardiography to determine left ventricular dysfunction[J]. Am Heart J, 2001, 141:367-374.

[4] Harrison A,Morrison LK, Krshnaswamy P, et al. Btype natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnca[J]. Ann Emerg Med, 2002, 39:131-138.

[5] Alan SM.Padma K,Richard MN,et al. Rapid measurement of Btype natriuretic peptide in the emergeney diagnosis of heat failure[J]. N Engl J Med, 2002,347:161-167.

[6] Catuzzo B,Ciancamerla F,Bobbio M,et al.In patients with severe systolic dysfunction,only brain natriuretic peptide is related to diastolic restrictive pattern[J]. J Card Fail, 2003,9(4):303-310.

[7] Maisel A. Btype natriuretic peptide in the diagnosis and management of congestive heart failure[J]. Cardiol Clin, 2001, 19(4):557-571.

[8] Remme WJ, Swedberg K.Guidelines for the diagnosis and treatment of chronic heart fail[J]. Eur Heart J, 2001, 22:1527-1260.

[9] Colao A,Marzullo P,Di Somma C,et al .Growth hormone and the heart[J]. Clin Endocrinol, 2001,54(2):137-154.

备注/Memo

备注/Memo:
收稿日期:2005-07-25.作者简介:孙卫红,副主任医师,硕士Tel:(0512)50805259 Email:rosy1105@163.com
更新日期/Last Update: 2010-01-06